Answer
Atrovent UDVs (ipratropium bromide) are contraindicated in people with known hypersensitivity to atropine, its derivatives (including ipratropium bromide), or any other component of the product.
Sources for this answer
- Atrovent 250 UDVs, 1 ml / Atrovent UDVs, 2 mlBoehringer Ingelheim Limited · emc · SmPC §4.3 Contraindications · Version 18Document updated
Sources checked